UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Tumor-Selective Induction of Apoptosis and the Small-Molecule Immune Response Modifier Imiquimod

JNCI : Journal of the National Cancer Institute, 2003-08, Vol.95 (15), p.1138-1149

2003

Volltextzugriff (PDF)

Statin therapy for venous ulcers

British journal of dermatology (1951), 2015-04, Vol.172 (4), p.1132-1133

2015

Volltextzugriff (PDF)

Imiquimod-induced regression of actinic keratosis is associated with infiltration by T lymphocytes and dendritic cells: a randomized controlled trial

British journal of dermatology (1951), 2006-01, Vol.154 (1), p.72-78

2006

Volltextzugriff (PDF)

A Randomized, Controlled, Molecular Study of Condylomata Acuminata Clearance during Treatment with Imiquimod

The Journal of infectious diseases, 1998-08, Vol.178 (2), p.551-555

1998

Volltextzugriff (PDF)

Microarray analysis of aberrant gene expression in actinic keratosis: effect of the Toll-like receptor-7 agonist imiquimod

British journal of dermatology (1951), 2007-12, Vol.157 (6), p.1132-1147

2007

Volltextzugriff (PDF)

Imiquimod induced regression of clinically diagnosed superficial basal cell carcinoma is associated with early infiltration by CD4 T cells and dendritic cells

Clinical and experimental dermatology, 2004-11, Vol.29 (6), p.639-643

2004

Volltextzugriff (PDF)

Topical immunomodulation under systemic immunosuppression: results of a multicentre, randomized, placebo-controlled safety and efficacy study of imiquimod 5% cream for the treatment of actinic keratoses in kidney, heart, and liver transplant patients

British journal of dermatology (1951), 2007-12, Vol.157 (s2), p.25-31

2007

Volltextzugriff (PDF)

Enhancement of the innate and cellular immune response in patients with genital warts treated with topical imiquimod cream 5

Antiviral research, 1999-08, Vol.43 (1), p.55-63

1999

Volltextzugriff (PDF)

Correlation between Pretreatment Levels of Interferon Response Genes and Clinical Responses to an Immune Response Modifier (Imiquimod) in Genital Warts

Antimicrobial Agents and Chemotherapy, 2000-07, Vol.44 (7), p.1869-1873

2000

Volltextzugriff (PDF)

Imiquimod 5% cream (Aldara™)

Expert opinion on investigational drugs, 1998-03, Vol.7 (3), p.437-449

1998

Volltextzugriff (PDF)

Imiquimod applied topically : a novel immune response modifier and new class of drug

International journal of immunopharmacology, 1999, Vol.21 (1), p.1-14

1999

Volltextzugriff (PDF)

Cytokine induction and modifying the immune response to human papilloma virus with imiquimod

EJD. European journal of dermatology, 1998-10, Vol.8 (7), p.13-16

SLADE, H. B

1998

Volltextzugriff (PDF)

Effect of immunization with inactivated gp120-depleted human immunodeficiency virus type 1 (HIV-1) immunogen on HIV-1 immunity, viral DNA, and percentage of CD4 cells

The Journal of infectious diseases, 1994-06, Vol.169 (6), p.1256-1264

1994

Volltextzugriff (PDF)

HIV type 1 isolate Z321, the strain used to make a therapeutic HIV type 1 immunogen, is intersubtype recombinant

AIDS research and human retroviruses, 1997-03, Vol.13 (4), p.357-361

1997

Volltextzugriff (PDF)

Proventil HFA Provides Bronchodilation Comparable to Ventolin Over 12 Weeks of Regular Use in Asthmatics

Chest, 1998-02, Vol.113 (2), p.283-289

1998

Volltextzugriff (PDF)

Proventil HFA and Ventolin Have Similar Safety Profiles During Regular Use

Chest, 1998-02, Vol.113 (2), p.290-296

1998

Volltextzugriff (PDF)

Inhibition of Functional Properties of Tetanus Antigen-Specific T-Cell Clones by Envelope Glycoprotein GP120 of Human Immunodeficiency Virus

Blood, 1990-01, Vol.75 (1), p.152-159

1990

Volltextzugriff (PDF)

Mucosal immunity: The immunology of breast milk

Journal of allergy and clinical immunology, 1987-09, Vol.80 (3), p.348-358

1987

Volltextzugriff (PDF)

Topical Resiquimod 0.01% Gel Decreases Herpes Simplex Virus Type 2 Genital Shedding: A Randomized, Controlled Trial

The Journal of infectious diseases, 2007-05, Vol.195 (9), p.1324-1331

2007

Volltextzugriff (PDF)

Antigen-driven immunoglobulin production by human colostral lymphocytes

Pediatric research, 1989, Vol.25 (3), p.295-299

1989

Volltextzugriff (PDF)

Detection of HIV-specific antibodies in infancy by isoelectric focusing and affinity immunoblotting

The Journal of infectious diseases, 1989-07, Vol.160 (1), p.126-130

1989

Volltextzugriff (PDF)

Review Article Imiquimod applied topically: a novel immune response modifier and new class of drug

International journal of immunopharmacology, 1999-01, Vol.21 (1), p.1-14

1999

Volltextzugriff (PDF)

Human Immunoglobulins for intravenous use and hepatitis C viral transmission

Clinical and diagnostic laboratory immunology, 1994-11, Vol.1 (6), p.613-619

Slade, H B

1994

Volltextzugriff (PDF)

HIV immunotherapy

Vaccine, 1994, Vol.12 (5), p.476-476

Slade, Herbert B.

1994

Volltextzugriff (PDF)

Measurement of immunoglobulin concentration in cell culture supernates by computer-assisted ELISA

Journal of immunological methods, 1986-11, Vol.94 (1), p.169-179

1986

Volltextzugriff (PDF)

1 – 25 von 323

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(259)
Mit Volltextzugriff
(255)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(197)
Life Sciences & Biomedicine
(179)
Humans
(124)
Female
(75)
Biological And Medical Sciences
(66)
Male
(60)
Medical Sciences
(52)
Adult
(51)
Middle Aged
(34)
Social Sciences
(31)
Business & Economics
(27)
Business, Finance
(27)
Economics
(27)
Business
(25)
Communication
(25)
Adolescent
(24)
Aged
(24)
Animals
(20)
Fundamental And Applied Biological Sciences. Psychology
(20)
Surgery
(20)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Tumor-Selective Induction of Apoptosis and the Small-Molecule Immune Response Modifier Imiquimod

Statin therapy for venous ulcers

Imiquimod-induced regression of actinic keratosis is associated with infiltration by T lymphocytes and dendritic cells: a randomized controlled trial

A Randomized, Controlled, Molecular Study of Condylomata Acuminata Clearance during Treatment with Imiquimod

Microarray analysis of aberrant gene expression in actinic keratosis: effect of the Toll-like receptor-7 agonist imiquimod

Imiquimod induced regression of clinically diagnosed superficial basal cell carcinoma is associated with early infiltration by CD4 T cells and dendritic cells

Topical immunomodulation under systemic immunosuppression: results of a multicentre, randomized, placebo-controlled safety and efficacy study of imiquimod 5% cream for the treatment of actinic keratoses in kidney, heart, and liver transplant patients

Enhancement of the innate and cellular immune response in patients with genital warts treated with topical imiquimod cream 5

Correlation between Pretreatment Levels of Interferon Response Genes and Clinical Responses to an Immune Response Modifier (Imiquimod) in Genital Warts

Imiquimod 5% cream (Aldara™)

Imiquimod applied topically : a novel immune response modifier and new class of drug

Cytokine induction and modifying the immune response to human papilloma virus with imiquimod

Effect of immunization with inactivated gp120-depleted human immunodeficiency virus type 1 (HIV-1) immunogen on HIV-1 immunity, viral DNA, and percentage of CD4 cells

HIV type 1 isolate Z321, the strain used to make a therapeutic HIV type 1 immunogen, is intersubtype recombinant

Proventil HFA Provides Bronchodilation Comparable to Ventolin Over 12 Weeks of Regular Use in Asthmatics

Proventil HFA and Ventolin Have Similar Safety Profiles During Regular Use

Inhibition of Functional Properties of Tetanus Antigen-Specific T-Cell Clones by Envelope Glycoprotein GP120 of Human Immunodeficiency Virus

Mucosal immunity: The immunology of breast milk

Topical Resiquimod 0.01% Gel Decreases Herpes Simplex Virus Type 2 Genital Shedding: A Randomized, Controlled Trial

Antigen-driven immunoglobulin production by human colostral lymphocytes

Detection of HIV-specific antibodies in infancy by isoelectric focusing and affinity immunoblotting

Review Article Imiquimod applied topically: a novel immune response modifier and new class of drug

Human Immunoglobulins for intravenous use and hepatitis C viral transmission

HIV immunotherapy

Measurement of immunoglobulin concentration in cell culture supernates by computer-assisted ELISA

Suchergebnisse filtern